To be able to analyze endogenous AGO2-ex1/3 protein expression in melanoma cells, we performed a genetic knockout of full-length AGO2 in the melanoma cell lines Mel Im and Mel Juso using CRISPR/Cas9. This evidence concerns the gene FRMD6 and melanoma.